載入...
INCREASING UTILIZATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (+) DONORS IN LIVER TRANSPLANTATION: IS IT SAFE?
BACKGROUND: Liver transplantation is the best treatment option for endstage liver disease. The Human T-Cell Lymphotrophic Virus (HTLV) has been associated with leukemia/lymphoma and progressive neurological disease. There has, however, been an increased utilization of HTLV (+) grafts with little dat...
Na minha lista:
Main Authors: | , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
2009
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2744350/ https://ncbi.nlm.nih.gov/pubmed/19384165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0b013e31819ebf76 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|